R. Taetle et al., Chromosome abnormalities in ovarian adenocarcinoma: II. Prognostic impact of nonrandom chromosome abnormalities in 244 cases, GENE CHROM, 25(1), 1999, pp. 46-52
In a large series of ovarian carcinomas from 244 patients, 134 cases had ch
romosome rearrangements. We showed before that the pattern of chromosome br
eakpoints involved 21 separate chromosome regions nonrandomly and, in 90% o
f cases with breaks, the breakpoints occurred within 13 commonly involved r
egions. Log-rank and proportional hazards regression analyses showed that t
he aggregate presence of a chromosome breakpoint in any of 21 nonrandomly i
nvolved regions and breaks in 9 distinct regions (1p1, 1q2, 1p3, 3p1, 6p2,
11p1, 11q1, 12q2, and 13p1) were associated with reduced patient survival.
Breakpoints in other areas of the genome, including other nonrandomly invol
ved regions, were not associated with decreased survival. Because many case
s had breakpoints in more than one nonrandomly involved region, proportiona
l hazards regression was also used to analyze for effects of each nonrandom
ly involved region, controlling for effects of other regions. With this app
roach, only breakpoints within 1p1 and 3p1 retained independent, deleteriou
s effects on survival. Similarly, when nonrandomly involved regions were en
tered into a proportional hazards model containing clinical variables assoc
iated with altered patient survival (tumor grade, tumor stage, and residual
disease >1 cm after resection), only 1p1 (P = 0.007) and 3p1 (P = 0.04) we
re associated with independent, negative effects on survival. These studies
demonstrate that chromosome breakpoints within specific, nonrandomly invol
ved chromosome regions are associated with impaired survival in ovarian can
cers. Regions 1p1 and 3p1 are identified as areas of particular significanc
e and are appropriate targets for analytical techniques such as SAGE and mi
croarray analysis. Genes Chromosomes Cancer 25:46-52, 1999. (C) 1999 Wiley-
Liss, Inc.